Kelly A. Romano, Director at Athira Pharma, Inc. (ATHA), bought 42,400 shares at $2.42 ($100K) on 2024-06-24, disclosed to the SEC on 2024-06-25.
Open-market purchase of $100k ATHA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.26 | 15,000 | $34K | 33.8% |
| 2 | $2.42 | 27,400 | $66K | 66.2% |
| Total | $2.36 avg | 42,400 | $100K | 100% |
| Filing → |